Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01855451	Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma(HPVOropharynx)	unknown	Phase 3	189	Trans Tasman Radiation Oncology GroupOTHER	2	Nov 18, 2022	clinicaltrials
NCT01874171	Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC(De-ESCALaTE)	unknown	Phase 3	334	University of WarwickOTHER	3	May 8, 2017